Clinical Lab Products
  • Diagnostic Technologies
    • Anatomic Pathology
    • Clinical Chemistry
    • Digital Pathology
    • Flow Cytometry
    • Hematology & Serology
    • Immunoassay
    • Mass Spectrometry
    • Microbiology
    • Molecular Diagnostics
    • Point-of-Care
    • Urinalysis & Toxicology
  • Lab Products
    • Biochemicals & Chemical Reagents
    • Information Technology
    • Lab Automation
    • Lab Equipment
    • Lab Safety
    • Labware & Consumables
    • Quality Systems
  • Disease States
    • Allergy & Autoimmune
    • Cancer
    • Cardiovascular
    • Cerebrovascular
    • Dementias & Alzheimer’s
    • Diabetes & Metabolic Diseases
    • Infectious Diseases
    • Kidney Disease
    • Respiratory Disease
    • Sepsis
    • Womens Health
  • Lab Management
    • Accreditation
    • Company News
    • Compliance
    • Proficiency Testing
    • Resource Center
  • Resources
    • Podcasts
    • Webcasts
    • White Papers
    • Videos
  • Edition Archive

Select Page

Search Results for: covid-19

FDA Issues Emergency Use Authorization for the First 2019 Novel Coronavirus Diagnostic

FDA Issues Emergency Use Authorization for the First 2019 Novel Coronavirus Diagnostic

Posted by Steve Halasey | Feb 7, 2020 | Emerging & Zoonotic Diseases, Infectious Diseases |

Critical milestone reached in response to the Wuhan coronavirus outbreak.

Read More
Inside Track: Coronavirus Diagnostics

Inside Track: Coronavirus Diagnostics

Posted by Steve Halasey | Jan 27, 2020 | Emerging & Zoonotic Diseases, Infectious Diseases |

Labs gear up to do battle with a potent pathogen.

Read More
  • 1
  • …
  • 368
  • 369
  • 370

Recent Posts

  • FDA-Approved PD-L1 Companion Diagnostic Expanded to Esophageal and GEJ Carcinoma
  • FDA Grants CLIA Waiver for Rapid Test That Differentiates Bacterial and Non-Bacterial Respiratory Infections
  • Large Study Shows Genetic Risk Results Can Be Returned to Thousands of Patients—With Caveats
  • DPYD Testing Gaps Leave Colorectal Cancer Patients at Risk for Severe Drug Toxicity
  • CSF Liquid Biopsy Delivers 82% Clinical Impact Rate in CNS Lymphoma Cases

Clinical Lab Products

7300 W 110th St – Floor 7
Overland Park, KS 66210
(913) 955-2600

Our Parent Company

MEDQOR LLC

About MEDQOR

MEDQOR Data Platform

Press Releases

Key Resources

Podcasts

Webinars

White Papers

Videos

Helpful Links

Media Solutions Kit

Subscribe Now

Contact Us

Submit an Article

  • Follow
  • Follow
  • Follow

Copyright

Privacy Policy

Terms of Service

© 2024 MEDQOR LLC. All Rights Reserved

✖